tiprankstipranks
Trending News
More News >
Tvardi Therapeutics (DE:69C)
FRANKFURT:69C
Germany Market

Tvardi Therapeutics (69C) Stock Investors

Compare
1 Followers
Based on 796,960 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold DE:69C
On average, investors allocate 0.00% of their portfolios to DE:69C
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 796,960 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 69C

1.2%
Last 7
Days
3.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding DE:69C, out of 796,960 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

69C Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of investors who made their portfolios public
The table shows changes in 69C in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

69C Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Bristol-Myers Squibb
3.32%
-1.05%
-1.01%
103.18B
Healthcare
Cisco Systems
3.64%
-0.87%
+0.18%
218.97B
Technology
CVS Health
4.34%
-0.63%
+1.63%
87.75B
Healthcare
Delta Air Lines
4.58%
-0.94%
+1.04%
26.69B
Industrials
Marathon Digital Holdings
5.05%
-0.53%
-0.80%
4.84B
Financial
JD
4.74%
-0.84%
-0.84%
60.08B
Consumer Cyclical
Viking Therapeutics
3.89%
+0.59%
-0.48%
2.88B
Healthcare
Block
3.61%
-0.48%
+1.57%
33.66B
Technology
Nio
8.75%
-0.75%
-2.22%
8.16B
Consumer Cyclical
Lucid Group
5.38%
+0.01%
+2.31%
7.43B
Consumer Cyclical
Based on the activity of 796,960 active portfolios
Open your Smart Portfolio

69C Investor Analysis

DE:69C investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.2%
of DE:69C holders
are under 35
Average Segment Performance
Average P/E Ratio14.40
Beta5.58
Dividend Yield4.24%
DE:69C investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
40.9%
of DE:69C holders
are between 35–55
Average Segment Performance
Average P/E Ratio14.58
Beta14.30
Dividend Yield3.71%
DE:69C investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
51.9%
of DE:69C holders
are over 55
Average Segment Performance
Average P/E Ratio10.35
Beta7.90
Dividend Yield4.00%
Overview of age group and performance of DE:69C stock investors
See who invests in 69C according to age group and performance.

FAQ

How many retail Investors hold DE:69C?
<0.1% of TipRanks' retail investors hold DE:69C in their portfolios.
    What is DE:69C Investor Sentiment?
    DE:69C’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of DE:69C in the last 7 days?
      ▼ 1.2% of TipRanks' retail investors changed their holding of DE:69C in the last 7 days.
        What percentage of retail investors changed their holding of DE:69C in the last 30 days?
        ▼ 3.6% of TipRanks' retail investors changed their holding of DE:69C in the last 30 days.
          What is the average age of retail investors who hold DE:69C?
          The average age of DE:69C Holders is over 55.
            What other stocks have DE:69C investors also bought?
            DE:69C Investors also bought BMY, CSCO, CVS, DAL, MARA, JD, VKTX, XYZ, NIO, LCID.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              CORCencora
              ANGOAngioDynamics
              BSXBoston Scientific
              CNCCentene
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis